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The Atg1–kinase complex tethers Atg9-vesicles to
initiate autophagy
Yijian Rao1,*, Marco G. Perna1,*, Benjamin Hofmann1, Viola Beier1 & Thomas Wollert1
Autophagosomes are double-membrane vesicles that sequester cytoplasmic material for
lysosomal degradation. Their biogenesis is initiated by recruitment of Atg9-vesicles to the
phagophore assembly site. This process depends on the regulated activation of the
Atg1–kinase complex. However, the underlying molecular mechanism remains unclear. Here
we reconstitute this early step in autophagy from purified components in vitro. We find that
on assembly from its cytoplasmic subcomplexes, the Atg1–kinase complex becomes
activated, enabling it to recruit and tether Atg9-vesicles. The scaffolding protein Atg17 targets
the Atg1–kinase complex to autophagic membranes by specifically recognizing the membrane
protein Atg9. This interaction is inhibited by the two regulatory subunits Atg31 and
Atg29. Engagement of the Atg1–Atg13 subcomplex restores the Atg9-binding and
membrane-tethering activity of Atg17. Our data help to unravel the mechanism that controls
Atg17-mediated tethering of Atg9-vesicles, providing the molecular basis to understand
initiation of autophagosome-biogenesis.
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T
he homeostasis of cells depends critically on recycling
pathways to remove superfluous or damaged cytoplasmic
material1. During macroautophagy, to which we will
refer to as autophagy in the following, cytoplasmic cargo is
engulfed by a cup-shaped membrane, termed phagophore.
Formation of such phagophores requires, in addition
to canonical membrane remodelling and fusion machines,
a dedicated set of autophagy-related (Atg) proteins2. Most
Atg-proteins have first been identified in yeast3–5, but many of
them possess mammalian homologues, emphasizing the high
degree of conservation among eukaryotes6.
Autophagy is initiated at the phagophore assembly site (PAS)
in yeast, to which Atg-proteins and donor-membranes are
recruited in a spatiotemporally coordinated manner7,8.
Sequestration of cargo from the cytoplasm involves expansion
of the phagophore. Sealing of the membrane generates the
double-membrane surrounded autophagosome. Enclosed
autophagic cargo is finally delivered to the vacuole for
degradation9.
Although Atg-proteins have been studied extensively9, a
central question in autophagy research concerning the
nucleation of autophagosomes remained unclear. A recent
study suggests that an average of three Atg9-vesicles coalesce at
the PAS10. The recruitment of these vesicles depends on the
scaffolding protein Atg17, which is the earliest protein to arrive at
the PAS7. Atg17 adapts a highly elongated crescent shape11,12 and
constitutively interacts with Atg29 and Atg31 in vivo, forming a
trimeric complex (Atg17TC in the following)13,14. On autophagy
induction, Atg1 and Atg13 assemble with Atg17TC into the
pentameric Atg1–kinase complex (Atg1PC in the following)13,15.
Interestingly, mammalian homologues of Atg1 (ULK1/2),
Atg13 (ATG13) and potentially Atg17 (FIP200) have been
identified16–18. Moreover, the ULK1-complex regulates mATG9
localization and is involved in early steps of autophagy,
suggesting that yeast Atg1- and mammalian ULK1/2-complexes
possess similar activities in autophagy19,20. Initiation of
mammalian autophagy occurs, however, at specialized
ER-domains, termed omegasomes6. Thus, although mammalian
and yeast autophagy pathways share conserved elements, both are
driven by distinct yet to be characterized mechanisms.
Atg1PC integrates nutrient dependent signals from other
kinases such as the protein kinase A (PKA) and the target of
rapamycin complex (TORC) 1 (refs 21,22). Under vegetative
conditions, TORC1 phosphorylates Atg13, preventing its
interaction with Atg17 (ref. 23) and thus the assembly of
Atg1PC from its subunits. On deactivation of TORC1 Atg13
becomes partially dephosphorylated and functional Atg1PC
assembles at the PAS24.
Significant progress has been made in the past to decipher the
function of Atg1PC as well as its interaction with Atg9-
vesicles12,23,25,26. The molecular mechanism of Atg1PC-activation
and how this translates into its regulated interaction with Atg9
remained, however, elusive. Here we analysed for the first time the
Atg1PC-Atg9-interaction in a fully reconstituted in vitro system
using purified components. Our results show that the Atg17-dimer
binds two Atg9-vesicles independently and functions as vesicle-
tether without contacting the membrane directly. The Atg31–Atg29
subcomplex sterically blocks the Atg9-binding site in Atg17 such
that Atg17TC becomes inactive. On autophagy induction, the
pentameric complex Atg1PC assembles and restores the full
Atg9-binding and vesicle-tethering activity of Atg17.
Results
Reconstitution of Atg1PC in vitro. To study the intricate
interplay of Atg1PC and Atg9-vesicles in a fully reconstituted
system, we purified individual subunits and subcomplexes to
incrementally assemble full-length Atg1PC from its components
(Fig. 1a, Supplementary Fig. 1a). Recombinant Atg1 was
phosphorylated at T226 (Supplementary Fig. 1b, Supplementary
Table 1), representing the active enzyme that functions in
autophagy27,28. In contrast to the recombinant Atg1-MIT-
domain, which dimerized in solution12,25, full-length Atg1 was
monomeric (Supplementary Fig. 1c). Atg17TC was produced by
co-expressing Atg17, Atg31 and Atg29 or by combining Atg17
with co-expressed Atg31–Atg29. Atg17 and Atg17TC form
well-characterized S-shaped dimers with dimerization being
mediated by the C-terminus of Atg17 (refs 11,12). To confirm
that our recombinant Atg17 and its related complex form similar
dimers, we determined their Stokes radii (RH) using dynamic light
scattering (DLS). Atg17 and Atg17TC possessed very similar RH of
10.4±0.1 nm and 10.3±0.1 nm (±refers to s.d., n¼ 3),
respectively. Thus, Atg17 and Atg17TC form extended
dimers comparable to those observed previously11.
Correspondingly, the C-terminally truncated variants Atg17mono
(Atg171–354) and Atg17monoTC, which lack the dimerization
domain, are monomeric (RH¼ 5.3±0.1 nm and
5.6±0.2 nm,±refers to s.d., n¼ 5).
Atg1 and Atg13 formed a stable subcomplex and incubating
both with Atg17TC resulted in the formation of Atg1PC (Fig. 1a,b,
Supplementary Fig. 1d). Multi-angle light scattering (MALS)
revealed that Atg1PC is a dimer of pentamers (Supplementary
Fig. 1e). Although the Atg1–Atg13 subcomplex contributes
two-thirds of the total mass of Atg1PC, the RH (B13 nm) of
Atg1PC is only slightly larger than that of Atg17TC. Atg1, Atg13
and Atg29 have been reported to contain intrinsically disordered
regions that are involved in intermolecular interactions that
stabilize Atg1PC (refs 29,30). Moreover, previous electron
microscopy studies showed that the overall S-shaped structure
of Atg17TC was not perturbed upon binding of the C-terminal
domains of Atg1 and Atg13 (ref. 30). These observations are in
agreement with our data demonstrating that Atg1PC has similar
overall hydrodynamic properties as Atg17TC. Moreover, our
results show that N-terminal domains of Atg1 and Atg13 do not
significantly increase the RH of the complex, suggesting that Atg1
and Atg13 form a compact subcomplex that partially occupies the
Atg17-crescent. The monomeric variant Atg17monoTC assembled
with Atg1–Atg13 into monomeric Atg1PC (Atg1monoPC) as
demonstrated by a shift in the retention volume (VR) from
10.2ml (Atg1PC) to 12.6 ml (Atg1monoPC) in size exclusion
chromatography (Supplementary Fig. 1f). Thus, complex
formation and Atg17-mediated dimerization are independent of
each other.
Atg1 and Atg13 are membrane-binding proteins. The
C-terminal tandem MIT-domain of yeast Atg1 has been found to
bind highly curved membranes in vitro12. To what extend
full-length Atg1 targets fully assembled Atg1PC to membranes
remained, however, elusive.
To address this question, we analysed membrane binding of
individual Atg1PC-components. While Atg17 and Atg17TC did
not interact with membranes of any curvature, both Atg1 and
Atg13 were efficiently recruited to highly curved membranes
composed of yeast polar lipid (YPL) extracts (Supplementary
Fig. 1g).
To test whether specific lipids are recognized by Atg1 and
Atg13, we compared binding to small unilamellar vesicles
(SUVs) made of YPL-extracts with that to SUVs containing
synthetic lipid mixtures. Acidic SUVs containing 10mol% or
40mol% phosphatidylserine (PS) did not facilitate Atg1 or
Atg13 recruitment. Interestingly, however, Atg1 strongly bound
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phosphatidylinositol (PI)-containing SUVs. Replacing 5mol% PI
by PI(3)-phosphate (PI(3)P) enhanced Atg1 recruitment
further (Fig. 1c). By contrast, Atg13 was only recruited to SUVs
prepared from YPL-extracts, suggesting that other lipids than
those present in tested synthetic mixtures are required for Atg13
binding (Fig. 1c). We next investigated whether full-length
Atg1PC is targeted to membranes by Atg1 and Atg13.
Using floatation assays we found similar membrane-binding
characteristics of Atg1PC (Fig. 1d) compared with those of Atg1
(Supplementary Fig. 1g). The specificity of Atg1 for PI-containing
membranes of high curvature is consistent with the localization of
Atg1PC in vivo. Atg1PC is one of the earliest complexes
to assemble at the PAS followed by Atg13-mediated recruitment
of the autophagy specific PI(3)-kinase complex31. The conversion
of PI to PI(3)P within autophagic membranes occurs, thus,
downstream of Atg1 (ref. 32).
Atg17 binds the conserved Atg9-core to promote autophagy.
During autophagy, Atg1PC assembles at the PAS and
recruits Atg9-vesicles in order to initiate the formation of
autophagosomes10,33. Thus lipid-binding as observed for Atg1
and Atg13 needs to be complemented by a specific recognition of
Atg9. Atg17 is the first Atg1PC-subunit to arrive at the PAS on
induction of autophagy7, which is followed by Atg17-dependent
recruitment of Atg9-vesicles34. We therefore aimed to compare
binding of Atg17, Atg17TC and Atg1PC to Atg9-vesicles in a fully
reconstituted system using purified components. Atg9 possesses
in addition to weakly conserved and mostly disordered N- and
C-terminal regions a highly conserved core region (Atg9core in
the following), which corresponds to the ubiquitously expressed
metazoan Atg9A-orthologue. We therefore focused on Atg9core
(Fig. 2a) and studied its interaction with Atg1PC.
We first confirmed that Atg9core retained its capacity to bind
Atg17 in vivo by co-immunoprecipitating HA-tagged Atg9core
with Atg17GFP (Supplementary Fig. 2a). Next, we reconstituted
recombinant Atg9core in proteoliposomes (Atg9–PLs). Circular
dichroism (CD) spectroscopy of detergent-solubilized and
purified Atg9core revealed the protein to be correctly folded
(secondary structure content of 77.5%), possessing an a-helix
content of 46.2% (Supplementary Fig. 2b), which is comparable to
that of similar membrane proteins35. Assessing the orientation of
reconstituted Atg9core in PLs by protease protection revealed that
B50% exposed their cytoplasmic domain to the exterior,
adapting the native membrane topology (Supplementary Fig. 2c).
We next tested whether Atg17 directly interacts with Atg9–PLs
and found that Atg17 was indeed recruited to Atg9–PLs, but not to
liposomes lacking Atg9 in co-floatation assays (Fig. 2b,
Supplementary Fig. 2d). To determine which region in Atg9
contributes to Atg17-recognition, we further truncated Atg9core to
produce deletion variants in which the entire N-terminal domain
(Atg9DN), the cytoplasmic domain between
transmembrane helix two and three (Atg9DcD), or both domains
(Atg9DNDcD) were missing (Fig. 2a). CD-spectroscopy confirmed
that all recombinant Atg9-variants were correctly folded
(Supplementary Fig. 2b). In contrast to Atg9core, which did not
prefer a specific orientation, Atg9-variants were incorporated such
that their cytoplasmic domains were facing the exterior. The
orientation of Atg9-variants in PLs is thus similar to the native
topology of Atg9 in vivo. (Supplementary Fig. 2c). As a
consequence, the amount of accessible binding sites is larger than
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Figure 1 | Reconstitution of Atg1PC from purified components. (a) SDS–PAGE of recombinantly expressed and SEC-purified Atg1–kinase complex
subunits. Atg17TC and Atg17monoTC were co-expressed; Atg1–Atg13, Atg1PC and Atg1monoPC were reconstituted from single components. (b) SEC elution
profiles of Atg1PC (red) compared with that of Atg17TC (green) and Atg1–Atg13 subcomplexes (blue). (c) Liposome sedimentation assays of Atg1
and Atg13. Lipid specificity of Atg1 and Atg13 was assessed by comparing their interaction with SUV containing 10mol% PS ([PS]k), YPL-extracts,
40mol% PS ([PS]m), 30mol% PI, or 25mol% PI supplemented with 2.5mol% PI(3)P. S, supernatant; P, pellet. (d) Floatation assay of YPL-large unilamellar
vesicles (LUVs) and MLVs of different sizes with Atg1PC. Atg1PC is efficiently recruited to membranes with high curvature (red box). Cartoons represent
subunits and complexes.
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though more binding sites are available in PLs containing
Atg9-variants, a strong reduction in co-floating Atg17 was
observed (Supplementary Fig. 2d). To eliminate the interference
of Atg9 on the intensity of Atg17-signals, we quantified co-floating
myc-tagged Atg17 (Atg17myc) by immunoblotting (Fig. 2b,
Supplementary Fig. 2e). All Atg9-variants were strongly impaired
in recruiting Atg17 by460%, indicating that both N-terminal and
cytoplasmic domains of Atg9 are crucial for Atg17-binding.
To investigate binding of Atg17 to Atg9 and its variants in vivo,
we complemented yeast atg9D cells with atg9WT, atg9DN
(D281–315), atg9DcD (D424–507), and atg9DNDcD in trans.
We first analysed whether Atg9-variants are forming peripheral
Atg9-pools using subcellular fractionation as previously
reported33 and found distribution-profiles of Atg9-variants
under autophagy-induced conditions to be comparable to that
of Atg9WT under vegetative conditions (Supplementary Fig. 2f).
We next studied binding of Atg17 to Atg9. As reported
previously34, Atg17 co-immunoprecipitated Atg9 even under
vegetative conditions and inducing autophagy by starvation
strongly enhanced their interaction (Fig. 2c). Consistent with our
in vitro data, we observed a strongly decreased interaction of
Atg17 with Atg9DN, Atg9DcD and Atg9DNDcD under vegetative
conditions, which was entirely abolished on starvation (Fig. 2c).
We inferred from these results that due to the missing interaction
of Atg17 with Atg9-variants, Atg9-vesicles are not recruited from
peripheral pools to the PAS, which is consistent with previous
observations7,34. Consequently, autophagic activity which we
quantified using Pho8D60-assays was strongly decreased in
atg9DN, atg9DcD, and atg9DNDcD cells (Fig. 2d). Our data thus
demonstrate that both N- and cD-domains are required for
Atg17-binding to facilitate efficient autophagy.
Competition between Atg9 and Atg31 regulates Atg17 activity.
We identified a stable C-terminal degradation product of Atg17,
which apparently retained the capacity to interact with Atg9. This
fragment contained the entire helix a4 of Atg17 and its
C-terminal dimerization-domain (Fig. 3a). The corresponding
recombinantly expressed Atg17-fragment (Atg17235–417) was
dimeric as expected. Moreover, co-floatation experiments
demonstrated that Atg17235–417 indeed strongly interacted with
Atg9–PLs (Fig. 3b). To further narrow down the potential
Atg9-binding site in Atg17, we expressed Atg17235–354
(lacking the dimerization domain, thus being monomeric) and
Atg17354–417 (dimerization domain) separately. Although both
constructs bind Atg9–PLs to a certain extent, binding of
Atg17235–354 was much stronger than that of Atg17354–417,
suggesting that the N-terminal part of a4 harbours the primary
binding site for Atg9 (Fig. 3b). Interestingly, Atg31 occupies a
similar region in Atg17 (ref. 36; Fig. 3a). To investigate whether
Atg31 and Atg9 compete with each other, we performed







































































































Figure 2 | Cytoplasmic domains of Atg9 interact with Atg17 to promote autophagy. (a) The scheme shows the topology of Atg9 in membranes
(transmembrane domains, pink cylinders; membrane bilayer in grey; cD, cytoplasmic domain). The grey bar represents Atg9WT, the pink bars illustrate
Atg9-variants with corresponding domain borders indicated by numbers. (b) a-myc immunoblot of co-floatation assays of Atg9-PL, containing Atg9core or
its variants, with Atg17. Large unilamellar vesicles (LUVs) lacking Atg9 served as a control for unspecific membrane binding. Proteins, recombinant Atg17
and Atg9–PLs used for experiments. (c) Immunoprecipitation (IP) of Atg17myc from ATG9WT, ATG9DN, ATG9DcD, ATG9DNDcD and ATG9D lysates under
vegetative conditions and after 2 h of starvation. Atg9-variants contained the very N- (1–280) and C-terminal (779–997) unstructured regions, which were
not present in Atg9core (indicated by the prefix fl), because these regions are essential for proper trafficking of Atg9 in vivo10,49,50. Atg17 and
co-immunoprecipitated Atg9-variants were detected by a-myc and a-HA immunoblots as indicated. Atg17 strongly interacts with wild-type Atg9, but not
with Atg9 lacking N-, cD- or both domains. Bottom panel: total protein amounts in cell lysates. (d) Pho8D60 assay of vegetative (white bars) and starved
(black bars) ATG9WT, ATG9DN, ATG9DcD, ATG9DNDcD and ATG9D. The Pho8D60 activity of starved ATG9WTwas set to 100% and used for normalization.
Mean values±s.d. of N¼ 3 independent experiments are shown.
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increasing stoichiometric amount of purified Atg31–Atg29
subcomplex (Fig. 3c). Remarkably, Atg31–Atg29 strongly
inhibited Atg17 for Atg9-binding. In the presence of equimolar
amounts of Atg17 and Atg31–Atg29, only B30% of Atg17 was
recovered from the Atg9-PL fraction (Fig. 3d).
The interaction interface between Atg17 and its regulatory
Atg31–Atg29 subcomplex is composed of two C-terminal
a-helices of Atg31 (residues 160–196), which form a helical
bundle with Atg17 (Fig. 3a). We therefore predicted that
Atg31160–196 efficiently inhibits binding of Atg17 to Atg9
in vivo given that a similar molecular mechanism as observed
in our reconstituted system regulates Atg17 activity in yeast. To
test this hypothesis, we co-immunoprecipitated Atg9HA with
Atg17myc from cell lysates which were incubated with increasing
amounts of recombinant, purified GST-Atg31160–196 (Fig. 3e).
We observed a strong and concentration-dependent decrease in
co-immunoprecipitated Atg9 (Fig. 3e), resulting in B20%
residual binding on incubation with one to five mg GST-
Atg31160–196, which amounts to concentrations between 60 and
300 nM GST-Atg31160–196 in cell lysates (Fig. 3f). The estimated
concentration of Atg17 in cell lysates (based on a Atg17-copy
number ofB500 per cell26 and 50 OD yeast cells in 500 ml lysate)
isB15 nM. Thus Atg31160–196 is a strong competitive inhibitor of
the Atg17–Atg9 interaction. The residual B20% binding activity
might be attributed to an Atg17-independent interaction of
Atg1PC with Atg9, which has recently been found to be mediated
by Atg13 (ref. 14). We next confirmed that the inhibitory effect of
GST-Atg31160–196 is caused by direct and competitive interaction
with Atg17 by co-immunoprecipitating Atg17 with
GST-Atg31160–196 (Supplementary Fig. 3). In summary, our
in vitro and in vivo data show that the Atg31–Atg29 subcomplex
regulates binding of Atg17 to Atg9. Moreover, the direct physical
interaction between Atg17 and Atg9 appears to dominate other
interactions of Atg1PC-subunits with Atg9 in vivo, since
Atg31160–196 strongly inhibits binding of Atg17 to Atg9. Thus,
the interaction of Atg1PC with Atg9-vesicles appears to be
controlled by a direct and tightly regulated binding of the
scaffolding subunit Atg17 to Atg9 in vitro and in vivo.
The Atg1–Atg13 subcomplex activates Atg17TC. Under
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Figure 3 | Atg9 binds the central crescent of Atg17. (a) Cartoon representation of the crystal structure of Atg17TC (pdb 4HPQ). Helix a4 (orange and green)
spans the entire Atg17-crescent and forms part of the dimerization domain (green). Domain borders that have been used to design Atg17-variants are indicated
by numbers. The minimal Atg17-binding region of Atg31 is highlighted in red with numbers indicating corresponding domain borders. Images were prepared in
PYMOL (The PyMOL Molecular Graphics System, Version 1.2r3pre, Schro¨dinger, LLC). (b) SDS–PAGE gel of co-floatation experiments of Atg9–PLs with
recombinant thioredoxin-tagged Atg17-fragments. Thioredoxin-tag lacking Atg17 (w/o Atg17) and co-floatation with large unilamellar vesicles (LUVs) lacking
Atg9core served as controls. Input corresponds to 10% of total protein used for co-floatation. (c) a-myc immunoblot of co-floatation experiments of Atg17 with
Atg9–PLs and increasing stoichiometric ratios of Atg31–Atg29. After incubating Atg9–PLs with Atg17, purified Atg31–Atg29 was added. Atg31–Atg29 inhibits
binding of Atg17 to Atg9 in vitro. (d) Quantification of Atg17 retrieved from the floating fraction in co-floatation experiments with Atg9–PLs as shown in c. The
intensity of the Atg17-band in the absence of Atg31–Atg29 was set to one and used for normalization. Mean values±s.d. of N¼ 3 independent experiments are
shown. (e) Immunoprecipitation (IP) of Atg17myc from cell lysates after 2 h of starvation. Increasing amount of GST-Atg31160–196 as indicated or 5mg GSTwere
added to cell lysates prior IP. Atg17 and co-immunoprecipitated Atg9 were detected by a-myc and a-HA immunoblots. (f) Quantification of Atg9HA as shown
in e. The intensity of the Atg9HA-band (w/o GST-Atg31160–196) was set to one and used for normalization. Mean values±s.d. of N¼ 3 independent
experiments are shown. P values were calculated using two-tailed Student’s T-test (*Po0.05; **Po0.01; ***Po0.005).
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in its inactive state. On starvation, however, Atg1–Atg13
associates with Atg17TC at the PAS to initiate autophagy. In
context of the observed competition between Atg9 and
Atg31–Atg29, we predicted that Atg1–Atg13 activates Atg17TC to
restore Atg9-binding. We thus compared binding of Atg17,
Atg17TC and Atg1PC with Atg9–PLs (Fig. 4a).
Atg9–PLs used in this study were prepared from synthetic lipid
mixtures lacking PI. Consequently, Atg1 and Atg13 were not
recruited to Atg9–PLs in the absence of Atg17 or Atg17TC
(Supplementary Fig. 4a). Consistent with our competition
assay, co-purified Atg17TC was strongly impaired in Atg9
binding. However, combining Atg1–Atg13 with Atg17TC fully
restored the binding capacity of Atg17 (Fig. 4b,c, Supplementary
Fig. 4b). In agreement with our and other data that only Atg13
directly contacts Atg17, Atg1 alone did not and Atg13 alone
partially activated Atg17TC for Atg9 binding (Fig. 4b,c).
To confirm that this mechanism of activation regulates Atg17
activity in vivo and thus autophagy initiation, we co-immuno-
precipitated Atg9HA with Atg17myc from cell lysates of starved
wildtype, atg1D, and atg13D cells (Fig. 4d). Consistent with our
observations in vitro, deletion of atg1 had a minor impact on the
interaction of Atg17 and Atg9. In the absence of Atg13, however,
a reduction in co-immunoprecipitated Atg9 by B70% was
observed (Fig. 4e). In conclusion our experiments suggest that the
constitutive Atg17-Atg31–Atg29 complex7,15 is inactivated by
occlusion of the Atg9-binding site. On autophagy induction,
Atg17TC recruits Atg1–Atg13 to the PAS7,15 and their direct
interaction releases the inhibition of Atg17 to restore its full
Atg9-binding capacity.
The recruitment of Atg9-vesicles by Atg17 to the PAS is one of
the earliest steps in autophagy. We thus investigate whether





























































































































































Figure 4 | The activity of Atg17 is regulated by Atg31–Atg29 and Atg1–Atg13 subcomplexes in vitro and in vivo. (a) The schematic drawing illustrates the
experimental set-up of floatation assays. (b) a-myc immunoblot from co-floatation experiments of Atg9–PLs with recombinant myc-tagged Atg17 with and
without other Atg1PC-subunits as indicated. Similar experiments with large unilamellar vesicles (LUVs) lacking Atg9core served as controls for unspecific
membrane binding. Input corresponds to 10% of total protein used for co-floatation. (c) Semiquantitative analysis of immunoblots as shown in b from
co-floatation experiments of Atg17myc with Atg9–PLs in the presence of other subunits of Atg1PC as indicated. All Atg17myc-intensities were corrected for
Atg9-intensities. The band intensity of Atg17myc (w/o other Atg1PC-subunits) was set to one and used for normalization. Mean values±s.d. of N¼ 3
independent experiments are shown. P values were calculated using two-tailed Student’s T-test (*Po0.05; **Po0.01; ***Po0.005). (d) Immunoprecipitation
(IP) of Atg17myc from lysates of wildtype (WT), atg1D and atg13Dcells after two hours of starvation. Atg17 and co-immunoprecipitated Atg9 were detected by
a-myc and a-HA immunoblots as indicated. (e) Quantification of Atg9HA as shown in d. The intensity of the Atg9HA-band in wildtype (WT), atg1D, and
atg13D cells were corrected for unspecific binding of Atg9HA in the control (Ctrl, cells w/o myc-tag). The WT Atg17-band intensity was set to one and used for
normalization. Mean values±s.d. of N¼ 3 independent experiments are shown. (f) Co-localization of Atg9-tandem-mCherry with Atg17-tandem-GFP in
wildtype (WT) and atg13D cells under vegetative and autophagy-induced conditions. Arrowheads indicate positions of non-colocalizing Atg9-puncta. Scale
bar, 2mm. (g) Quantification of relative co-localization of Atg17-puncta with Atg9-puncta (number of co-localizing puncta per cell, normalized by number of
Atg17 puncta per cell) in WT, atg1D, and atg13D cells under vegetative (white bars) and autophagy-induced (black bars) conditions. Mean values±s.d. of
N¼ 3 independent experiments are shown (4200 cells per strain were examined).
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using wildtype, atg13D and atg1D cells. In the wild-type
background, multiple Atg17-negative Atg9-puncta were detected
under vegetative conditions and inducing autophagy increased
the relative co-localization of both proteins drastically (Fig. 4f,g).
A similar co-localization was observed in atg1D cells, arguing that
Atg13 itself sufficiently activates Atg17TC (Fig. 4g, Supplementary
Fig. 4c) By contrast, autophagy induction did not promote
co-localization of Atg17 and Atg9 in atg13D cells, demonstrating
that inhibited Atg17TC is strongly impaired in recruiting
Atg9-vesicles to the PAS (Fig. 4f,g).
The dimerization domain of Atg17 is involved in regulation.
Our observation that the dimerization domain of Atg17 is
dispensable for Atg9-binding (Fig. 3b) prompted us to investigate,
whether monomeric Atg17 is regulated in a similar manner as
observed for full-length Atg17. We thus compared binding of
Atg17mono, Atg17monoTC and Atg17monoPC with Atg9-PL using
floatation assays. Consistent with our data that helix a4 of Atg17
harbours the primary Atg9-binding site, Atg17mono was
efficiently recruited to Atg9–PLs (Fig. 5a). Remarkably,
Atg17mono was much stronger inhibited by Atg31–Atg29 as it
has been observed for Atg17. Moreover, Atg1–Atg13 was not able
to release this strong inhibition (Fig. 5a), although both sub-
complexes assemble into stable Atg1monoPC (Supplementary
Fig. 1f). Thus, the dimerization domain of Atg17 is apparently
involved in regulating Atg17-function. The strong inhibition of
Atg1monoPC also demonstrates that membrane binding of Atg1
and Atg13 per se does not contribute to enhanced binding of
full-length Atg1PC to Atg9–PLs.
We next tested whether the residual Atg9-binding activity of
Atg17monoTC and Atg1monoPC suffices to induce autophagy.
Consistent with previous findings12, autophagy is strongly
impaired in cells expressing Atg17mono (Fig. 5b). This earlier
study also demonstrated that the autophagy-defect was caused by
an impaired recruitment of Atg8 to the PAS12. Since Atg17
functions upstream of Atg8, we investigated whether Atg17mono
localizes to the PAS by analysing mCherry-Atg17- and
GFP-Atg8-puncta formation in cells expressing Atg17 or
Atg17mono (Fig. 5c). We performed these experiments in
atg11D cells to prevent Cvt-mediated GFP-Atg8-puncta
formation. As expected, both Atg17 and Atg8 were recruited
to the PAS in cells expressing full-length Atg17 under
autophagy-induced conditions. Interestingly, however, neither
Atg8- nor Atg17-puncta were observed in Atg17mono expressing
cells. (Fig. 5c). Thus, expression of Atg17mono inhibits early steps
in autophagy, arguing that dimerization of Atg17 itself is
important for its proper localization and function in vivo.
Atg1PC is a membrane-tethering complex. Our data revealed the
mechanism that regulates Atg17 activity, implying that
dimerization of Atg17 is important for its targeting to and
activation at the PAS. Moreover, the S-shaped structure11,12 of
Atg17TC suggests that one Atg17-dimer binds two Atg9-vesicles
independently. We thus tested whether Atg17 has
membrane-tethering activity by measuring the RH of Atg9–PLs
in the presence and absence of Atg17 using DLS.
Atg9–PLs are polydisperse in solution, indicating that they are
clustering. This is consistent with previous data showing that
Atg9 possesses a highly conserved self-interacting motif that is
required for Atg9-trafficking and function in vivo37.
To circumvent Atg9-mediated self-interaction, we prepared
Atg9–PLs in the presence of either Atg17 (Atg9–Atg17–PLs) or
Atg17mono. In contrast to SUVs lacking Atg9 (RH¼ 60±2 nm,
Fig. 6a), Atg9–Atg17–PLs possessed an RH of 135±2 nm
(±refers to s.d., n¼ 5), indicating two Atg9–PLs to be tethered
together by dimeric Atg17. To exclude that other effects
than specific tethering cause Atg9–PLs to appear larger by




























































































Figure 5 | The dimerization domain of Atg17 regulates Atg17-function. (a) a-myc immunoblots from co-floatation experiments of Atg9–PLs with
recombinant myc-tagged, monomeric Atg17 (Atg17mono), Atg17monoTC and Atg1monoPC. Atg17mono is strongly inhibited by Atg31–Atg29, but Atg17monoTC is
not activated by Atg1–Atg13. Similar experiments with large unilamellar vesicles (LUVs) lacking Atg9core served as controls. Input corresponds to 10% of
total protein used for co-floatation. (b) Pho8D60 assay of wildtype (WT), atg17mono, and atg17D cell lysates to assess autophagic activity under vegetative
(grey bars) and starvation (black bars) conditions. Mean values±s.d. of N¼ 3 independent experiments are shown. (c) Co-localization of GFP-Atg8 with
mCherry-tagged Atg17 or Atg17mono under vegetative or autophagy-induced conditions. Atg17mono is not forming puncta under autophagy-induced
conditions. Consequently, autophagosomes are not being formed as apparent from the lack of Atg8-puncta. Scale bar, 2mm.
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Atg9–Atg17mono–PLs (RH¼ 65±1 nm, (refers to s.d., n¼ 5) was
similar to that of corresponding SUVs lacking Atg9core (Fig. 6a).
Thus, dimerization of Atg17 is required to tether Atg9–PLs.
Atg17 constitutively interacts with Atg31–Atg29 in vivo and we
demonstrated that Atg17 is inhibited by Atg31–Atg29 for
Atg9-binding in vitro and in vivo (Fig. 3c,d). We therefore tested
whether this inhibition impacts on tethering. Atg9–PLs, prepared
in the presence of Atg17TC and Atg17monoTC were monodisperse
with a RH of 72±2 nm and 82±2 nm (±refers to s.d., n¼ 5),
respectively (Fig. 6b,c). Thus Atg31–Atg29 does not only interfere
with Atg9-binding, it also regulates tethering of Atg9–PLs by
Atg17. Consequently, Atg1–Atg13-mediated activation of
Atg17TC should promote membrane-tethering by Atg1PC. In
fact, Atg9–Atg1PC-PLs were found to be twice the size
(RH¼ 180±4 nm) of corresponding SUVs lacking Atg9core
(RH¼ 87±2 nm,±refers to s.d., n¼ 5) (Fig. 6b,c). Consistent
with our data on Atg17TC-regulation (Fig. 4c), Atg1 alone did not
promote tethering of Atg9–PLs by Atg17TC. In the presence of
Atg13, however, Atg9–Atg17TC–PLs were significantly larger
(RH¼ 105±5 nm) and polydisperse (22±3% compared to
12–16% in other samples,±refers to s.d., n¼ 5), indicating that
a mixture of tethered and dispersed vesicles is present in these
samples (Supplementary Fig. 5a). Thus, Atg13 partially activates
Atg17TC, which allows the resulting complex to tether Atg9–PLs,
but with lower efficiency compared with Atg17 or Atg1PC.
Furthermore, Atg1monoPC was deficient in tethering Atg9–PLs
(Fig. 6b), demonstrating that dimerization and activation of
Atg17 are required to tether Atg9-vesicles.
Since DLS is an indirect measurement for vesicle tethering, we
set out to visualize this process by cryoelectron microscopy. We
found that Atg9–Atg17–PLs are 20–50 nm in diameter (Fig. 6d,
Supplementary Fig. 5b,c), closely resembling the size of
Atg9-vesicles that are recruited to the PAS to nucleate the
phagophore in vivo10. Most importantly, however, the majority of
such vesicles was found to be tethered, resulting in two vesicles
contacting each other (Fig. 6d, Supplementary Fig. 5b,d).
Consistent with our DLS measurements, Atg9–Atg17mono–PLs
and Atg9–Atg17TC–PLs were homogeneously dispersed with
diameters similar to that of Atg9–Atg17–PLs (Supplementary
Fig. 5b,c). In contrast, multiple Atg9–PLs were contacting each
other in the presence of Atg1PC (Fig. 6d, Supplementary Fig. 5b, d).
Moreover, Atg1PC-mediated tethering progressed from two
vesicles to multiple vesicles, resulting in a steady increase in RH
and polydispersity in DLS measurements over time. Interestingly,
an average of three Atg9-vesicles have been shown to coalesce at
the PAS to nucleate the phagophore10, which is consistent with our
finding that Atg1PC tethers multiple vesicles.
Phosphorylated Atg13 is deficient in activating Atg17TC. Under
vegetative conditions, Atg13 is phosphorylated by TORC1
(ref. 24), preventing its interaction with Atg17 and thus the
assembly of Atg1PC at the PAS13,23. In order to recapitulate
phosphoregulation in vitro, we made use of the kinase activity of
recombinant Atg1. By adding ATP to fully assembled Atg1PC, the
electrophoretic mobility of Atg13, Atg29 and Atg1 shifted on
SDS–PAGE gels, indicating these proteins to be phosphorylated
by Atg1 (Supplementary Fig. 6a). We thus determined the
phosphorylation sites by mass spectrometry. Surprisingly, many















































































Figure 6 | Atg1PC tethers Atg9–PLs. (a) The hydrodynamic radius of SUVs (white bar) and Atg9–PLs (black bar) obtained from DLS-experiments in the
absence or presence of Atg17 and corresponding variants as illustrated by cartoons are shown. ND, not determinable (polydisperse). (b) Similar
experiments shown in a were performed for Atg17 and Atg17-variants and that of corresponding Atg17TC and Atg1PC (sub)complexes. (a,b). Mean
values±s.d. of N¼ 5 experiments are shown for both a and b. P values were calculated using two-tailed Student’s T-test (*Po0.05; **Po0.01;
***Po0.001). (c) The schematic drawing illustrates the experimental setup and summarizes the results obtained from DLS-experiments in a and b.
(d) Cyro-electron micrographs of Atg9–PLs from samples used for DLS-experiments containing Atg17, Atg17TC, Atg17mono, and Atg1PC. Atg17 tethers two
and Atg1PC tethers multiple vesicles together. Scale bar, 50 nm.
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response to nutrient conditions in vivo, are phosphorylated
by Atg1–kinase in vitro (Supplementary Table 1). The
observed phosphorylation patterns in vitro did, however, not
recapitulate starvation-induced regulation in vivo since Atg29 is
phosphorylated, but Atg13 is dephosphorylated on autophagy
induction24,29.
We next tested whether Atg1PC is disassembled on
phosphorylation. In fact, SEC and SDS–PAGE of SEC-fractions
demonstrated that Atg1PC dissociated on phosphorylation into
Atg17TC and Atg1–Atg13 (Fig. 7a, Supplementary Fig. 6b,c).
Interestingly, although Atg13 was phosphorylated at several
positions including serine (S)496 within the C-terminal MIM,
which contacts Atg1, the Atg1–Atg13(P) subcomplex remained
tightly associated. Consistent with previous findings that
phosphorylation of S428 and S429 in Atg13 prevents its
interaction with Atg17 (ref. 23), both residues were
phosphorylated on ATP-addition to Atg1PC.
As indicated above, phosphorylation of Atg1, Atg13 and Atg29
is caused by promiscuous Atg1–kinase activity in vitro. To
investigate the specific impact of Atg13-phosphorylation on
Atg17-regulation, we therefore made use of the recently described
phosphomimic mutant Atg13S428D,S429D (Atg13SD)23. Consistent
with this study, SEC-profile and SDS–PAGE of SEC-fractions
demonstrate that the Atg1–Atg13SD subcomplex does not
interact with Atg17TC (Fig. 7a, Supplementary Fig. 6d).
Moreover, Atg1–Atg13SD did not activate Atg17TC for
Atg9-binding (Fig. 7b). Consequently and consistent with all data
in our study, Atg1–Atg13SD did not promote tethering of Atg9–PLs
by Atg17TC (Fig. 7c).
In summary, our in vitro reconstitution study revealed
important aspects of Atg1PC-function, including its assembly,
regulation, disassembly, as well as its interaction with and
tethering of Atg9-vesicles.
Discussion
The Atg1–kinase complex assembles at the PAS upon
dephosphorylation of Atg13 (refs 13,24), where it extensively
regulates autophagosome biogenesis38. However, the molecular
function of Atg1PC during phagophore biogenesis, its regulation
as well as its intricate interplay with Atg9 remained controversial.
In this study, we revealed the molecular mechanism of Atg1PC-
activation and how this impacts on its interaction with
Atg9-vesicles. The key elements of this study comprise:
(1) reconstitution of full-length Atg1PC from purified subunits
to investigate assembly, disassembly and regulation of Atg1PC as
well as (2) reconstituting Atg9core in proteoliposomes to
biochemically dissect interactions of both components in vitro
and in vivo. Our results led to a comprehensive model for
Atg1PC-function, revealing insights into the molecular basis to
initiate autophagy. We found that Atg17 has membrane-tethering
activity, which is inhibited by the regulatory Atg31–Atg29
subcomplex. On dephosphorylation of Atg13, the Atg1–Atg13
subcomplex engages Atg17TC to assemble Atg1PC. This releases
the steric inhibition of Atg17, allowing Atg9 to bind the central
crescent of Atg17. Consequently, each of the two Atg17-subunits
















































































































Figure 7 | Phosphorylation of Atg13 disassembles Atg1PC and prevents tethering. (a) SEC elution profiles of Atg17TC in the presence of Atg1–Atg13
(red), Atg1–Atg13SD (blue), and Atg1–Atg13þATP (green). Atg13SD and addition of ATP prevents assembly of Atg1PC. (b) a-myc immunoblot of
co-floatation experiments of Atg9–PLs with recombinant myc-tagged Atg17 and Atg17TC without and with Atg1–Atg13 (Atg1PC) or Atg1–Atg13SD (ref. 23).
Similar experiments with large unilamellar vesicles (LUVs) lacking Atg9core served as controls. Input corresponds to 10% of total protein used for
co-floatation. (c) The hydrodynamic radius of SUVs (white bar) and Atg9–PLs (black bar) with similar samples as shown in (b) obtained from
DLS-experiments. Mean values±s.d. of N¼ 5 experiments. (d) Model for Atg1PC function, tethering of Atg9-vesicles, and its regulated assembly from and
disassembly into subcomplexes. P indicates phosphorylation of Atg13 under vegetative conditions.
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The most interesting insight of our study concerns the
molecular function of Atg1PC and its subunits at the PAS. A
previous study established that an average of three Atg9-vesicles,
30–60 nm in size, coalesce at the PAS to nucleate the
phagophore10. Here we demonstrate that Atg1PC is a
membrane-tethering factor, which specifically recognizes
Atg9-vesicles of high curvature. The principle membrane-
tethering subunit of Atg1PC is Atg17, which has been shown to
form elongated, S-shaped dimers in solution11,12. We could show
that Atg31–Atg29 occludes the Atg9-binding site in Atg17,
preventing Atg9-vesicles from being recruited under non-induced
conditions by constitutive Atg17TC. Molecular basis for this
competition are at least overlapping binding sites of Atg31160–196
and cytoplasmic domains of Atg9 in Atg17. Atg31160–196 forms a
four-helical bundle with Atg17 by directly contacting helices a1
and a412. Atg17-helix a4 also harbours the Atg9-binding site,
thus preventing recruitment of Atg9 when Atg31 occupies the
Atg17-crescent. The interaction of Atg17 with Atg9–PLs was
depleted by 70–80% when Atg31–Atg29 was added to
preassembled Atg17–Atg9–PLs in vitro or when Atg31160–196
was added to cell lysates in vivo. This suggests that a direct
inhibition of Atg17 by Atg31–Atg29 is a key determinant in
regulating the recruitment of Atg9-vesicles to the PAS in response
to starvation. Moreover, the minimal Atg17-binding region of
Atg31 is a very potent inhibitor of Atg17. Adding increasing
amounts of Atg31160–196 to cell lysates which resulted in
concentrations well above the estimated total concentration of
Atg17 did, however, not result in full inhibition of the
Atg17–Atg9 interaction. Residual binding might be mediated by
Atg13, which has recently been found to bind Atg9 in vitro and
in vivo26.
Assembly of Atg1PC from its Atg17TC and Atg1–Atg13-
subcomplexes restores binding of Atg17 to Atg9 and promotes
tethering of Atg9–PLs in vitro. The direct contact between both
subcomplexes is mediated by Atg13, which directly interacts with
Atg17 (refs 15,39). This implies that the activation of Atg17
requires at least Atg13. In agreement with this notion, we found
that not only the interaction between Atg17 and Atg9 is
significantly impaired in atg13D cells, but also targeting of Atg9
to the PAS. Moreover, the phosphomimicking mutant
Atg13S428,429D does not form a pentameric complex with
Atg17TC, thereby preventing Atg17 from interacting with and
tethering of Atg9–PLs. A recent structural study identified the
Atg13-binding site in Atg17, comprising helices a3 and a4 and
being in close proximity to Atg31 (ref. 23). Moreover, the
Atg31–Atg29 complex was suggested to be flexibly connected to
Atg17 (ref. 12), thereby potentially adopting alternative
conformations. Altogether with our observation that Atg13
activates Atg17TC for Atg9-binding in vitro and in vivo, it
appears plausible that Atg13 induces a conformational
rearrangement in Atg17TC, such that Atg31–Atg29 move away
from the central crescent to expose the Atg9-binding site of
Atg17. This model is supported by our observation that although
Atg13 did not directly interact with Atg9core, because Atg9core
lacks the previously identified Atg13-binding site26, Atg13
restores binding of Atg17TC to Atg9–PLs to promote tethering
of Atg9-vesicles. We therefore propose a model in which Atg13
exerts two different activities. First, Atg13 cooperates with Atg17
in recruiting Atg9-vesicles to the PAS by direct recognition of
Atg9. Furthermore, Atg13 activates Atg17TC such that fully
assembled Atg1PC binds and tethers Atg9-vesicles through its
scaffolding subunit Atg17 (Fig. 7d).
Interestingly, we observed a significant difference in
Atg1–Atg13-mediated activation of monomeric or dimeric
Atg17TC. Even though Atg17monoTC assembled together with
Atg1–Atg13 into stable Atg1monoPC in vitro, binding of Atg17 to
Atg9 was not restored. Consistently, the low residual binding
activity of Atg17monoTC and Atg1monoPC for Atg9 in vitro
correlates with a lack of Atg9-recuitment to the PAS in
Atg17mono-expressing cells. Atg17mono was, however, also not
recruited to the PAS on starvation, arguing that dimerization of
Atg17 is not only important for regulating Atg17 activity, but also
for its recruitment to the PAS.
Another interesting aspect of our study regards the
membrane-binding activity of Atg1 and Atg13. Although the
recombinantly expressed MIT-domain of Atg1 has been found to
recognize membranes previously12, it was not clear how this
affects Atg1PC. According to this study, we showed that
full-length Atg1 also binds highly curved membranes.
Moreover, we found that Atg1 possesses specificity for PI,
thereby targeting Atg1PC to PI-containing membranes with high
curvature. While the MIT-domain of Atg1 has no structural
similarity to canonical membrane binding domains23, a recent
study showed that homologous MIT-domains in Vps4 and
SNX15a bind PI and PI-phosphates as well40. Whether
MIT-domains represent a new class of PI-specific membrane
binding modules remains to be addressed by future studies. In
contrast to our findings that Atg17 and Atg9 are not sensing
membrane curvature, both proteins localize to the highly bent
membrane edges of the phagophore41. Given that Atg1 and
Atg13 sense curvature and that the Atg1–Atg13 subcomplex
interacts with Atg17 at the PAS, it is tempting to speculate that
Atg1–Atg13 restricts the localization of Atg17 and consequently
that of Atg9 at the phagophore. This implies, on the other hand,
that Atg1PC might not only tether vesicles for phagophore
nucleation, but also for phagophore expansion.
Methods
Reagents. Synthetic lipids 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphoethanolamine (POPE),
1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphoserine (POPS), 1-palmitoyl-2-oleoyl-
sn-glycerol-3-phosphoinositol (POPI), cholesterol, 1,2-dioleoyl-sn-glycero-3-
phospho-10-myo-inositol-30-phosphate (PI(3)-phosphate) as well as yeast polar
lipid (YPL) extracts were purchased from Avanti Polar Lipids. The detergent
n-Dodecyl-N,N-Dimethylamine-N-Oxide (LDAO) was from Anatrace.
The following antibodies were used in this study: aPep12p (Invitrogen, Catalog
No: 710037, 1:1,000 dilution), aPgk1p (Invitrogen, Catalog No: 459250, 1:10,000
dilution), aHA (Santa Cruz, sc-7392, 1:200 dilution,), and aMyc (Santa Cruz,
sc-789 and sc-40, 1:1,000 dilution), and aGFP antibodies (Roche, Catalog No:
11814460001).
Yeast strains and growth conditions. Derivatives of yeast strain Saccharomyces
cerevisiae BY4741 (Euroscarf) used for this study, are listed in Supplementary
Table 2. Genomic gene deletion and tagging was performed as described42.
Atg9-variants were ectopically expressed in atg9D cells. Therefore, the coding
sequences of the respective Atg9-variants were sub-cloned into the pTL58 vector
(pAtg9::Leu2) and transformed in atg17mycatg9D and pho8D60atg9D strains. To
adjust the expression levels of Atg9 to that of its variants, the Pma1-promoter in
pTL58-Atg9 was exchanged against the endogenous Atg9-promoter. To investigate
whether Atg9core is able to interact with Atg17 in vivo, pRS316-Atg9core-3xHA
(pPma1::URA3) was transformed into atg17GFPatg9D cells. To analyse the
regulation of Atg17 by Atg1 and Atg13 in vivo, pTL58-Atg9–3xHA (under control
of the Atg9-promoter, pAtg9::Leu2) was transformed into atg17myc9atg9Datg1D
and atg17myc9atg9Datg13D cells.
Co-localization of Atg17-variants and Atg8 was analysed by transforming
plasmids pTL58-Atg17(variants)-mCherry (pPma1::Leu2)) in atg8-GFPDatg11
Datg17D strains. To study the co-localization of Atg17 and Atg9, pTL58-Atg17-
2GFP (under control of its native promoter, pAtg17::Leu2) and pRS316-
Atg9-2xmCherry (under control of its native promoter, pAtg9::URA3) were
co-transformed into atg17Datg9D, atg17Datg9Datg1D, and atg17Datg9Datg13D cells.
Cells were grown in synthetic media (0.67% yeast nitrogen base, 0.5%
ammonium sulphate, 2% glucose, amino acids) at 30 C to mid-log phase. For
co-immunoprecipitation experiments and Pho8D60 assays, autophagy was induced
by starvation, cells were collected by centrifugation, washed twice and resuspended
in synthetic medium without amino acids (0.17% yeast nitrogen base, 2% glucose).
For fluorescence imaging, autophagy was induced by addition of rapamycin
(0.2 mgml 1, Sigma) for 1 h.
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Preparation of yeast cell extracts and immunoprecipitation. Yeast cells
corresponding to 50 OD600 (optical density at 600 nm) were collected by
centrifugation (3min, 1,500g), resuspended in ice-cold lysis buffer (25mM
Tris-HCl pH 7.2, 150mM NaCl, 0.2% NP-40 supplemented with protease inhibitor
cocktail (Sigma) and 3mM PMSF) and lysed by vortexing with acid washed glass
beads. Lysates were cleared by centrifugation (20min, 17,000g).
Immunoprecipitation was performed by incubating the cell lysates with an
a-myc antibody coupled to magnetic protein A beads (raised from murine B-cell-
hybridomas) or GFP-Trap-M beads (Chromoteck) for 2h at 4 C. For competition
assays, different amounts of recombinant, purified GST-Atg31160–196 were added
to lysate. For GST pull-down assay, 10 mg of GST or GST-Atg31160–196 was
incubated with cell lysate, prepared as described above. Lysates were incubated with
Glutathione Sepharose 4B beads, extensively washed with lysing-buffer containing
an additional 100mM NaCl and resuspended in SDS-sample buffer. Samples were
separated on NuPage Bis-Tris gels (Life Technologies) prior to immunoblotting.
Corresponding uncropped blots are shown in Supplementary Fig. 7.
Subcellular fraction assay. Yeast cells were grown to mid-logarithmic phase
(OD600 of 0.8–1.0) and autophagy was induced by treatment with 0.2 mgml 1
rapamycin for 1 h at 30 C. Cells corresponding to 500 OD600 were collected by
centrifugation (3min, 1,500g) and resuspended in 50-ml buffer containing 100mM
Tris-H2SO4, pH 9.4 and 10mM DTT. After incubation at 30 C for 10min, cells
were spheroblasted by resuspending them in 50ml synthetic medium containing
20mM Tris-HCl pH 7.5 and 1.0M sorbitol supplemented with 2.5 mg per OD600
zymolyase-100T (Biomol), and incubation for 30min at 30 C. Spheroblasts were
washed twice in 50ml synthetic medium containing 1.0M sorbitol and lysed in
5-ml ice-cold hypoosmotic buffer (50mM HEPES-KOH, pH 7.6, 200mM sorbitol,
1mM EDTA) containing complete protease inhibitors (Sigma) and 2mM PMSF
using 50 strokes in a Dounce homogenizer. The cell lysate was centrifuged
sequentially at 300g for 5min and 13,000g for 10min and 1.9ml of the supernatant
was loaded on top of a 22–60% sucrose step gradient. The gradient was prepared by
overlaying 0.5ml 60% sucrose with 1.0ml 37%, 1.5ml 34%, 2ml 32%, 2.0ml 29%,
1ml 27%, and 1.5ml 22% sucrose solution. After ultra-centrifugation at 170,000 g
for 17–18 h using a SW40Ti rotor (Beckman Coulter), 0.8 ml fractions were
collected from top to bottom and analysed by western blotting using aPep12p
(Invitrogen), aPgk1p (Invitrogen), aHA, and aMyc (Santa Cruz) antibodies.
Pho8D60 assay. Autophagic activity was assessed as described43. Briefly, yeast
cells corresponding to 4 OD600 were collected by centrifugation (3min, 1,500g) and
resuspended in ice-cold assay buffer (250mM Tris-HCl, pH 9.0, 10mM MgSO4
and 10 mM ZnSO4). Cells were lysed by vortexing with acid washed glass beads and
cleared by centrifugation (20min, 17,000g). 1-naphthyl-phosphate was added to
final concentration of 5mM and the enzymatic reaction was stopped after 20min
incubation at 30 C by adding one volume of stopping buffer (2M Glycin-NaOH,
pH 11.0). The enzymatic conversion of 1-naphthyl-phosphate by alkaline
phosphatases was determined by measuring the fluorescence with a TECAN
infinite M1000Pro using an excitation wavelength of 345 nm and detecting
emission at 472 nm. The fluorescence signal was corrected for the total protein
content in the respective sample as determined using the Pierce BCA protein assay
kit (Thermo Scientific).
Recombinant expression and purification of the Atg1PC-subunits. The
open reading frames encoding Atg1, Atg13, Atg17, Atg171–354, Atg17235–417,
Atg17235–354, Atg17354–417, Atg29, Atg31160–196 and Atg31 were amplified from
yeast S. cerevisiae BY4741 (Euroscarf) genomic DNA and cloned into pCoofy-
vectors with N- or C-terminal affinity-tags for expression in insect cells (Atg1) or
Escherichia coli (all others) by homologous recombination44. Oligonucleotides used
are shown in Supplementary Table 3. Atg17 and the Atg17-Atg31–Atg29 complex
as well as its monomeric variant Atg171–354-Atg31–Atg29 were (co)expressed from
the polycystronic vector pST39 (ref. 45) with a His6-tag fused to the N-terminus of
Atg17 or a myc-tag fused to the C-terminus of Atg17.
Atg1 was expressed in High Five (BTI-TN-5B1–4) cells applying the titerless
infected-cells preservation and scale-up (TIPS) method as described46. Cells were
resuspended in lysis buffer (100mM Tris-HCl, pH 7.4, 300mM NaCl, 20mM
imidazole, 5% glycerol, 5mM b-mercaptoethanol, protease inhibitor cocktail
(Sigma), benzonase (Sigma), 10Uml 1) supplemented with 1% Triton-X and
disrupted by high pressure homogenization. All other proteins were expressed in
E.coli Rosetta cells. Cultures were grown in LB-medium at 37 C until they reached
an OD600 of 1.0 and shifted to 18 C. Expression was induced by adding
Isopropyl-b-D-thiogalactopyranosid (0.1mM). The cells were collected by
centrifugation after 16 h and resuspended in lysis-buffer. Cells were disrupted by
sonication. All proteins were purified by Ni-nitrilotriacetate (Ni-NTA) affinity
chromatography, applying a linear imidazole gradient in running buffer (25mM
Tris-HCl pH 7.4, 300mM NaCl, 20mM or 1 M imidazole, 5% glycerol, 5mM
b-mercaptoethanol). For Atg1 purification, a running buffer supplemented with
0.1% Triton-X was used. The N- and C-terminal tags were cleaved by PreScission
protease digest for 30min at room temperature. Digested proteins were
immediately subjected to anion-exchange chromatography (Atg13) equilibrated
with 25mM Tris-HCl pH 7.4, 125mM NaCl, 5% glycerol, 2mM DTT or size
exclusion chromatography (SEC) on a HiLoad Superdex 200 prep grade column
(GE Healthcare) equilibrated with 25mM Tris HCl pH 7.4, 300mM NaCl, 5%
glycerol, 5mM b-mercaptoethanol. Fractions containing the protein of interest
were pooled, concentrated and further purified by Ni-NTA rechromatography.
Aliquots of the purified proteins were flash frozen in liquid nitrogen and stored at
 80 C until use. The Atg1–Atg13 subcomplex or Atg1PC and its monomeric
variant were assembled from purified subunits by incubating respective mixtures at
room temperature for 30min followed by gelfitration using a Superose 6 column.
Expression and purification of Atg9. The coding sequence of Atg9core
(Atg9281–779) was amplified from S. cerevisiae BY4741 and sub-cloned into a
modified pET28a(þ )vector (Novagen). Truncated constructs Atg9DN (residues
316–779), Atg9DcD (residues 316–423 and 508–779) and Atg9DNDcD were gener-
ated using the In-Fusion HD Cloning Kit (Clontech). Atg9core and its variants were
expressed in E. coli Rosetta cells as described above, but resuspended in buffer
containing 25mM Tris-HCl, pH 8.0 and 150mM NaCl. After lysing the cells with a
high-pressure microfluidizer, cell debris was removed by centrifugation
(10min, 24,000g). The supernatant was subjected to a second centrifugation step to
separate the membrane fraction (1 h, 150,000g). The membrane fraction was
resuspended in buffer containing 25mM Tris-HCl pH 8.0, 150mM NaCl, and
40mM LDAO (critical micelle concentration¼ 1mM) and incubated for 1 h at
4 C to solubilize the membrane proteins. Not solubilized material was removed
by ultracentrifugation (1 h, 150,000g) and the supernatant was purified by
Ni-NTA-chromatography as described above, with Atg9-buffer (25mM
Tris-HCl pH 8.0, 150mM NaCl, 4mM LDAO), supplemented with imidazole.
Atg9-containing fractions were pooled, concentrated and subjected to SEC using a
Superdex-200 10/300GL column (GE Healthcare) for further purification using
Atg9-buffer. Purified proteins were stored at  80 C until used as described above.
Circular dichroism spectroscopy. The quality of Atg9core preparations was
assessed using CD spectroscopy. CD-spectra of detergent-solubilized Atg9core
(-variants) were recorded using a JASCO J-715 spectrophotometer, covering a
190–250 nm spectral range, at 4 C and a path length of 0.1mm. The protein
concentration was determined by measuring the OD at 280 nm and the secondary
structure content of Atg9 was estimated by fitting experimental data with standard
curves using the contin-algorithm47, provided by the Jasco Standard Analysis
Program.
Liposome preparation and sedimentation. Liposome sedimentation assays were
performed to investigate protein–membrane interactions in the absence of Atg9.
Liposomes were prepared from mixtures of synthetic lipids containing 20mol%
cholesterol, 10mol% POPE, 60mol% POPC, 10mol% POPS or from YPL-extracts.
For liposomes containing 30mol% POPI, 25mol% POPIþ 2.5mol%
PI(3)-phosphate, or 40mol% POPS, the amount of POPC was adjusted accord-
ingly. A thin lipid film was produced in a glass vial by evaporating the chloroform
of the respective lipid-mixtures under a nitrogen-stream and subsequent incuba-
tion under vacuum. Multilamellar vesicles (MLVs) were generated by hydrating the
lipid film with hydration-buffer containing 25mM Tris-HCl pH 8.0, 150mM NaCl,
adjusted to a total lipid concentration of 1mgml 1. Large unilamellar vesicles
were produced by extruding the resulting MLV-suspension through filters with
appropriate pore size as indicated. SUVs were prepared by sonicating the
MLV-suspension on ice until the solution became clear followed by extrusion
through 30-nm pore-size filters.
Liposome sedimentation assays were performed by incubating 100-ml large
unilamellar vesicles or SUVs with the protein of interest (2 mM final concentration)
for 30min at room temperature. The liposomes were collected by centrifugation
(30min, 140 000 g, 4 C) for subsequent analysis using SDS–PAGE.
Reconstitution of Atg9 in liposomes and floatation assay. Atg9core or its
variants were reconstituted in liposomes using the rapid dilution approach.
Liposomes were prepared from mixtures of synthetic lipids containing 20mol%
cholesterol, 10mol% POPE, 60mol% POPC and 10mol% POPS, yielding a total
lipid concentration of 1mgml 1. After rehydration of liposomes, lipids were
resolubilized with LDAO yielding a final concentration of 6mM LDAO before
Atg9-variants were added. Atg9core-(variants) solubilized in 4mM LDAO were
added in a protein:lipid ratio of 1:200 and the mixture was 30-fold diluted with
hydration buffer and incubated for 30min at room temperature. Atg9 containing
proteoliposomes (Atg9-PL) were collected by centrifugation (30min, 150 000 g,
4 C), resuspended in 25mM HEPES pH 7.0, 100mM NaCl (interaction buffer)
and extruded using a filter pore size of 200 nm.
The orientation of Atg9 was assessed by incubating Atg9-PL with PreScission
protease (50Uml 1) at room temperature for 1 h. Proteolytical cleavage of the
C-terminal His-tag resulted in a significant band shift of the corresponding protein
on SDS–PAGE gels.
The interaction of Atg1PC, its subunits, or its subcomplexes with Atg9-PL was
assessed by floatation experiments. Therefore, 250ml of Atg9–PLs were mixed with
an equivalent volume of 80% Nycodenz in interaction buffer containing the
respective Atg1PC-subunits in a stoichiometric ratio of 1:1. A step gradient was
generated by overlaying this mixture with 250ml 30% Nycodenz and 100 ml
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interaction buffer. After centrifugation at 650,000g for 2 h (at 4 C), the top 100 ml
co-floated fraction contained accumulated Atg9–PLs (at the Nycodenz–buffer
interface) and bound interaction partners. This fraction was subsequently analysed
by SDS–PAGE and immunoblotting.
Dynamic light scattering. The protein amount used for tethering assays was
calculated according to the amount of Atg9–PLs with native orientation in the
membrane (50% of total protein). For each assay, 200 ml Atg9–PLs were mixed with
100ml protein of interest, yielding molar ratios of 1:1, diluted in 25mM HEPES
pH 7.0 and 100mM NaCl buffer and incubated at room temperature for 15min.
The mixture was co-sonicated at 4 C until the solution appeared clear (15min).
Dynamic light scattering was carried out at 4 C on a DynaPro NanoStar
Instrument (Wyatt) using 50-ml cuvettes and a total sample volume of 20 ml. Raw
data were analysed by the DYNAMICS software package. The dispersity of the
solution was assessed, and the average hydrodynamic radius (RH) was calculated.
Multi-angle light scattering. Size exclusion chromatography–MALS
(SEC–MALS) measurements were performed on a HP1100 HPLC system (Agilent)
using a Superdex-200 Increase 10/300GL (GE-Healthcare, Atg1) or a Superose-6
10/300GL (GE-Healthcare, Atg1PC) column. The MALS signal was recorded
on-line using a miniDAWN Treos MALS detector (Wyatt) and the corresponding
protein concentration was determined with an Optilab t-Rex RI detector (Wyatt).
Atg1 was injected at a concentration of 5mgml 1 and Atg1PC at a concentration
of 3.4mgml 1 in a volume of 50 ml and 100 ml, respectively. SEC–MALS data were
analysed using the Astra software package (Wyatt) applying the Zimm light
scattering model. The molar mass at the concentration peak apex (MW max,
refractive index peak apex) and the weight-average molar mass of the respective
peak (MW peak, ultraviolet peak borders selected by hand) were determined.
Tandem mass spectrometry. Proteins for tandem mass spectrometry were used
at a 1 mM concentration. Proteolytic digestion was performed over night with LysC
at RT and subsequently with Trypsin for 2 h at 37 C. For injection to the LTQ
Orbitrap (Thermo Fisher) tandem mass spectrometer, the resulting peptides were
separated by C18 reversed phase nanoscale liquid chromatography. Data were
analysed using the MaxQuant software package48.
Confocal microscopy. Images were acquired on a Zeiss LSM780 and a Leica TSC
SP8 laser scanning confocal microscope with  63/1.4 numerical aperture (NA)
objectives using the Zeiss ZEN 2011 and LAS AF software packages, respectively.
GFP and mCherry were excited with 488-nm and 561-nm laser light, respectively.
Multi-tracking mode was used for image acquisition on the Zeiss LSM780
microscope. Pinholes were set for acquiring 1.5–2.0 mm optical slices. All images
were analysed using ImageJ (Schneider et al., 2012) and Zeiss ZEN 2011 software
packages. For yeast cell imaging, 5ml yeast cells were grown to log phase and
treated with rapamycin for 1 h. Two hundred-microlitre samples were added to an
observation chamber (Lab-Tek #1.0 Borosilicate), which had been coated with
1mgml 1 concanavalin A (Sigma).
Cryo-EM analysis. Samples (5 ml co-sonicated Atg9–PLs) were applied to
lacey-carbon-grids (Quantifoil), blotted and frozen in liquid ethane using a
Vitrobot (FEI). Images were recorded on a CM120 FEG under low-dose conditions
with a 4k 4k CCD camera (TVIPS) and a defocus of  2 mm.
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